



Article  (Accepted Version)
http://sro.sussex.ac.uk
Kelly, Claire, Pericleous, Marinos, Ahmed, Ayesha, Vandrevala, Tushna, Hendy, Jane, Shafi, 
Shuja, Skene, Simon, Verma, Sumita, Edge, Chantal, Nicholls, Margot, Gore, Charles, de 
Lusignan, Simon and Ala, Aftab (2020) Improving uptake of hepatitis B and hepatitis C testing in 
South Asian migrants in community and faith settings using educational interventions - a 
prospective descriptive study. International Journal of Infectious Diseases. ISSN 1201-9712 
This version is available from Sussex Research Online: http://sro.sussex.ac.uk/id/eprint/93313/
This document is made available in accordance with publisher policies and may differ from the 
published  version or from the version of record. If you wish to cite this item you are advised to 
consult the publisher’s version. Please see the URL above for details on accessing the published 
version. 
Copyright and reuse: 
Sussex Research Online is a digital repository of the research output of the University.
Copyright and all moral rights to the version of the paper presented here belong to the individual 
author(s) and/or other copyright owners.  To the extent reasonable and practicable, the material 
made available in SRO has been checked for eligibility before being made available. 
Copies of full text items generally can be reproduced, displayed or performed and given to third 
parties in any format or medium for personal research or study, educational, or not-for-profit 
purposes without prior permission or charge, provided that the authors, title and full bibliographic 
details are credited, a hyperlink and/or URL is given for the original metadata page and the 
content is not changed in any way. 




Title:  Improving uptake of hepatitis B and hepatitis C testing in South Asian migrants 
in community and faith settings using educational interventions - a prospective 
descriptive study 
 
Authors: Claire Kelly1,2, Marinos Pericleous1,2, Ayesha Ahmed3, Tushna Vandrevala4, 
JaneHendy3, Shuja Shafi5 Simon Skene6, Sumita Verma7, Chantal Edge8, Margot 
Nicholls9,Charles Gore10, Simon de Lusignan2,11,12, Aftab Ala1,2, Email aftab.ala1@nhs.net 
1. Department of Gastroenterology and Hepatology, The Royal Surrey County Hospital, 
Guildford, Surrey, UK 
2. Department of Clinical and Experimental Medicine, Faculty of Health and Medical Sciences, 
University of Surrey, Guildford,UK 
3. Brunel Business School, Brunel University, London, UK 
4. Department of Psychology, Kingston University,  
London, UK 
5. Research and Documentation Committee, The Muslim Council of Britain, London, 
UK 
6. Clinical Trials Unit, University of Surrey, Guildford, Surrey, UK 
7. Department of Clinical and Experimental Medicine Brighton and Sussex Medical School and 
Department of Gastroenterology and Hepatology, Brighton and Sussex University Hospital, 
Brighton, UK 
8. Institute of Epidemiology and Health Care, UCL, London, UK 
9. Public Health England South East, UK 
10. The Hepatitis C Trust, UK 
11. Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK 
12. Royal College of General Practitioners Research and Surveillance Centre, London, UK 
 




Keywords: Viral hepatitis; case-finding; intervention; south asian; migrant 
Address for correspondence 
 
Professor Aftab Ala MB BS, MD, PhD, FRCP, Institute for Liver Studies, King’s College 




CVH: Chronic viral hepatitis 
SA: South Asian 
WHO: World Health Organization 
NICE: National Institute for Health and Care Excellence 
RCT: Randomized controlled trial 
DBS: dried blood-spot  
HBsAg: Hepatitis B surface antigen 
HBcAb: Hepatitis B core antibody  
HCV: Hepatitis C 













Background: Chronic viral hepatitis (CVH) is a leading contributor to the UK liver disease 
epidemic, with global migration from high-prevalence areas (e.g. South Asia-SA). Despite 
international guidance for testing high-risk groups in line with elimination targets, there is no 
consensus on how to achieve this. 
Objectives: (i) Feasibility of recruiting SA migrants to view an educational film on CVH (ii) 
Effectiveness of the film in promoting testing, knowledge of CVH (iii) Methodological issues 
relevant to scale-up to randomized trial. 
Methods: We recruited SA migrants to view the film (intervention) in community venues 
(primary care, religious, community), offering dried-blood spot CVH testing immediately 
afterwards. Pre/post-film questionnaires assessed the interventions effectiveness. 
Results: Two hundred and nineteen first generation migrants >18yrs (53% female) were recruited 
to view the film;184 (84%) underwent CVH testing (HBc Ab or HCV Ab positive, demonstrating 
exposure in 8.5%) at the following sites:  n=112 (51%) religious, n=98(45%) community, and 
primary care, n=9 (4%). Pre (n=173, 79%) and post (n=154, 70%) intervention questionnaires 
were completed.  
Conclusions: We demonstrate the feasibility of recruiting first generation migrants to participate 
in a community-based educational film, promoting CVH testing in this higher-risk group, 
confirming value of developing interventions to facilitate global WHO plan for targeted case 
finding, elimination and future randomized controlled trial.  We highlight the importance of 
culturally relevant interventions including faith, and culturally sensitive settings appearing to 
minimize logistical issues effective at engaging minority groups and allowing ease of access to 
individuals ‘at risk’ 
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The UK faces an ever growing burden of chronic liver disease and its sequelae at a time of 
significant improvements in the morbidity and mortality of other chronic diseases [1]. A 
significant contributor to this is chronic viral hepatitis (CVH), a leading cause of liver disease 
worldwide [2]. National and international guidance stress the importance of efforts to close 
the CVH prevalence gap, through case-finding and ultimately treatment. This will minimize 
the burden of liver disease and its complications, as well as reducing onward transmission of 
CVH in keeping with the World Health Organization (WHO) call for elimination of CVH as 
a public health problem by 2030 [3]. CVH tends to be most prevalent amongst groups who 
traditionally experience barriers to healthcare e.g. prisoners, drug users and migrants, 
Therefore, targeted interventions are required to increase confidence and testing amongst 
these groups with the ultimate aim to reduce inequalities in treatment and disease burden for 
these high risk groups.  
 
Despite this impetus to case-find, it is unclear whether interventions are effective in achieving 
this goal. The rate of CVH infection amongst migrants is higher than the background UK 
population and is believed to be related to the prevalence in the country of origin [4]. Migrant 
populations experience poorer health and barriers to accessing services both in the UK [5] 
and internationally [6], with communication and cultural differences likely contributors to the 
increased morbidity and mortality seen in minority ethnic groups with CVH [7].  
In the UK, the National Institute for Health and Care Excellence (NICE) and NHS England 
(NHSE) advocate promoting testing in higher-risk groups, such as migrants from moderate to 




high prevalence areas (e.g. South Asian countries) [2].   NICE recommend community based 
interventions, however no guidance is given on how to target at risk populations [2]. There is, 
therefore, a need to develop tailored interventions to promote case finding in higher-risk 
groups who traditionally experience barriers to healthcare access e.g. prisoners, drug users 
and migrants, increase confidence and testing amongst these groups, with the ultimate aim to 
reduce inequalities in treatment/disease burden for these groups.  
The evidence base for case-finding healthcare interventions is centered around population 
based screening programs [8]. Whilst evidence exists on factors influencing an individual’s 
likelihood of screening uptake, the literature is less conclusive over the effectiveness of 
different intervention types, being limited by heterogeneity of data collection and analysis 
[8,9]. However, culturally relevant interventions including the importance of faith, language 
and culturally sensitive settings and those that minimize logistical issues may be more 
effective at engaging minority groups [9]. We have developed a short, culturally and 
linguistically tailored educational film based on qualitative data collected, surrounding the 
knowledge, perceptions, barriers and fears of CVH infection and testing in South-Asian 
populations [10,11]. In this paper we report on the feasibility of recruiting members of South-
Asian communities in England to view the film, and subsequently accept CVH screening.  
 
At the time of writing, we did not identify evidence surrounding the use of an educational 




Materials and Methods  




Our aims were to  
 
1. Determine the feasibility of recruiting South-Asian migrants residing in South-East 
England to view a short educational film based on qualitative data collected from our 
previous study[10, 11]  
 
2. Determine the effect of this educational intervention on the (i) uptake of CVH testing in 
community settings (ii) understanding of viral hepatitis  
 
3. Identify methodological issues which may compromise the acceptability and feasibility of 
a definitive randomized controlled trial (RCT) of this intervention  
 
Study design (figure 1) 
Development of the Film Intervention  
 
We used qualitative data to inform the development of a short (12 minute) film to explain 
CVH, modes of transmission and how to access testing (https://youtu.be/K3AYyZ3uHro 
(English) and https://youtu.be/dapPV4oul9s (Urdu with English subtitles)). We undertook 
eight focus groups with men (n=26) and women (n=27) from South-Asian communities to 
understand their knowledge and views on CVH and the role of community based testing. 
Thematic analysis led to the generation of key areas to address in the film [10, 11].  
 
Participants stressed the importance of personal stories from the community, therefore the 
film included testimonies of first-generation South-Asian migrants with experience of testing 
for CVH, including those who tested negative and those previously treated. The film was 




produced by a professional film-maker with experience in directing and producing 
educational healthcare films [12]. The content and style were edited with input from 
stakeholders and thereafter piloted within the target community to ensure understanding and 
suitability of language (spoken Urdu with English subtitles). Urdu was chosen because it was 
the language used by many of the local SA community. The subtitles were also available in 
other SA languages as required. 
 
Recruitment and Film screening  
Participants were recruited to view the educational film in community settings from February 
to June 2018 (religious venues, community centers and primary care facilities) in South-East 
England. Initially, recruitment was centered around Surrey, however, due to concerns about 
potential contamination of study sites within this area, i.e. participants visiting different study 
sites, recruitment was widened to other centers in Greater London, including Hounslow, 
Wandsworth and Merton. Seventeen film screenings occurred in fourteen different venues 
including four primary care, four community and six religious venues. The community 
venues were a mixture of existing social groups based on ethnicity (mixed gender and 
religion) and support groups for education and language lessons for new female migrants. 
The religious venues were all Mosques.  The film was shown twice in two of the religious 
venues (once for each gender) and twice in the same community setting due to the increased 
interest from the community. 
 
Critically, guidance on recruitment was provided through the help and support of community 
stakeholders e.g. community advocates e.g. primary care doctors, community nurses and 
pharmacists and community champions e.g. faith leaders, councilors.  Initial contact from 
multilingual members of the research team was made with each target site (e.g. faith leader 




leader) to explain the nature of the study. When agreement to participate with sites was 
reached, the research team visited again, outlining the project aims and developing 
community links. Participant information sheets were delivered and a suitable area to show 
the film identified. Two weeks prior to the date of scheduled film screening, an advertising 
campaign in conjunction with community leaders was carried out with multilingual posters 
advertising a health educational event. Further advertising depended on the type of venue:  
 
a. Religious: Religious leader announced the event at key attendance times, e.g. main prayers  
b. Community: Community center organizer announced a planned health education event to 
regular attendees  
c. Primary care: Healthcare staff identified patients from the target population and distributed 
participant information sheets, research team contacts and date of film screening.  
 
The film was shown in group sessions with variable attendance (n=1-80). We did not set a 
lower limit of attendance as it was felt inappropriate to cancel events as this could diminish 
trust in the research team.  
 
Inclusion/exclusion criteria:  
Inclusion criteria for this study were: first generation migrants self-identifying as South 
Asian, aged 18 years or over, able to give informed consent and communicate in English, 
Urdu or Hindi. The Ethics approval process highlighted we were providing healthcare 
education and accordingly, no one should be excluded from viewing the film. Those not 
meeting study inclusion criteria were able to view the film but not recruited to provide 
research data.  
 




Post-film CVH testing and linkage to care:  
Immediately after the film screening, participants were offered CVH testing. A return visit to 
the venue was scheduled for a week later if the number requiring testing was not manageable 
on the day or if participants wanted more time to consider testing.  
Consent for CVH testing was received separately and privately by a research clinician. As 
this study was community-based, we used finger-prick testing with dried blood-spot (DBS) 
kits for CVH testing (Abbott). This tests for Hepatitis B surface antigen (HBsAg), Hepatitis B 
core antibody (HBcAb), Hepatitis C (HCV) antibody (and reflex HCV RNA testing if 
antibody positive), and has a high sensitivity and specificity [13]. Each sample was tested in 
an accredited NHS laboratory, with results available within 7-10 days. Procedures for referral 
to health care services for treatment for a positive blood borne virus test were agreed in 
advance of testing.  
 
Pre- and post-film questionnaires (see appendix):  
To assess the effectiveness of the film, and to determine knowledge pre- and post-film, 
questionnaires were distributed to those who viewed the film. Questionnaires were designed 
using a combination of externally validated existing questions, and those designed for this 
study including knowledge of CVH, prior experience, utility of the film and intention to test. 
Answers were provided on a five point Likert scale, from strongly disagree to strongly agree.  
 
Statistical analysis  
The target sample size of 200 was derived to provide an estimate of the proportion seeking 
testing following the intervention, with suitable precision, and provides for a half-width of a 
95% confidence interval for this proportion in the region of 6-7% over a wide range (20-
80%) of possible values for this proportion. Due to the feasibility nature of this study, results 




are reported as descriptive statistics. Participant characteristics are presented as percentages 
for categorical variables. Two-sided 95% confidence intervals, where applicable, were 
calculated using StataIC 15.1 (Statacorp LP, College Station, TX).  
 
Study success criteria 
These included a. 40% (n=80) of participants watching the film will be tested. Previous pilot 
work demonstrated 15-20% uptake of testing without an intervention in a community setting 
[14]; b. 90% of participants viewing the intervention will complete the pre-film questionnaire 
and c. 80% of participants will complete the post-film questionnaire  
 
 This study received regulatory approval from the National Health Service Health Research 
Authority (17/LO/0881).  
 
Results  
Two hundred and twenty-one participants were recruited to view our educational film, across 
fourteen different venues from February to June 2018. Two participants were excluded as 
they were not first generation migrants. Therefore, two hundred and nineteen were included 
in the study (see figure 2). The majority were recruited from religious (n=112; 51%) or 
community settings (n=98;45%), and a minority from primary care (n=9; 4%).  
 
General characteristics: 
Demographic details were collected for study participants and are illustrated in table 1. The 
demographic details of those subsequently testing for CVH are shown in figure 3. Testing for 
CVH One hundred and eighty-four of the two hundred and nineteen (84%) participants tested 




for CVH after viewing our film (figure 2). The overall proportion of participants testing for 
CVH was similar across all types of site, as shown in figure 4.  
 
Results of pre- and post-intervention questionnaires:  
Of the two hundred and nineteen who viewed the film, 79% (n=173) completed the pre-
intervention questionnaire with 70% (n=154) completing the post-intervention questionnaire, 
which was less than predicted.  
 
A questionnaire was judged complete if any question was answered. However, many of the 
questionnaires had missing data points. Data was available for 65% (n=142) who filled in 
both questionnaires. This overall sample is skewed, with 82% (n=117 of responses) 
completed by those who tested; in keeping with the majority of participants who viewed the 
film also requested CVH testing. When reviewed by testing status, 64% of those who 
accepted testing and 66% of those who did not, completed both questionnaires. When asked 
if this film was useful, 86.6% (n=123) agreed or strongly agreed. There was no difference 
between tested and non-tested groups (86%; 88%). One person disagreed the film was useful 
(0.7%), but did undergo testing. The remainder (n=18, 12.7%) did not answer the question. 
Again, this was similar for those who did and did not test for CVH (13%; 12% respectively). 
Participants were asked to rate their confidence in understanding CVH. One hundred twenty 
participants responded (85%), with a similar proportion responding from tested and non-
tested groups. Knowledge was unchanged pre- and post-film in 31% (n=37). The majority of 
those reporting their knowledge was unchanged (n=21) were confident both before and after 
the film, a small number were not confident in their knowledge (n=6) and a further small 
number neither agreed nor disagreed (n=10). Knowledge improved (from either neutral/not 
confident to confident) post film in 58% (n=70). There appeared to be a trend towards 




improved knowledge post-film in the non-tested group (n=16; 64%) compared with tested 
(n=54; 46%). A small number reported a fall in confidence (from confident to not confident 
or neutral) in their knowledge (n=13; 11%). Prior experience of CVH was assessed as a 
possible confounding factor in testing; however, around one-third of respondents did not 
provide an answer. Few patients had any personal experience of CVH (n=8; 7% in the tested 
group and n=1; 4% in the non-tested group). There was some experience in a family member 
(n=34; 29% and n=5; 20% in the tested and non-tested groups respectively). However, 32% 
(n=77) and 44% (n=11) reported no experience of CVH in the tested and non-tested groups 
respectively. 
 
Word of mouth testing uptake:  
 
During a pre-arranged repeat visit at both a community and religious venue to test 
participants, members of the community who had not seen our film requested testing (n=31 
and n=14 respectively table 1b, figure 5). A clinician discussed this with each individual and 
obtained written informed consent prior to testing. All participants who approached us in this 
manner consented to testing, and mentioned their awareness of our community work and the 
film specifically. Anecdotally, they were informed about the nature of CVH and its 
transmission, stating they had obtained this information from others who viewed the film.  
 
Results of CVH testing:  
 
Of the two hundred and twenty-nine tested, (n=184 having viewed the film and n=45 testing 
through word of mouth), eighteen required a repeat test as the original result was 
inconclusive (equivocal result, smaller sample size affecting sensitivity of the test) but opted 




not to have this done.  These 18 participants were excluded from further analysis. Eighteen 
(8.5%) participants of the 211 tested with valid results had exposure to CVH (see figure 6). 
There were no infections detected in primary care patients. There were no HCV exposures in 
the community venues. There were, however, five cases of previous HBV exposure (HBcAb) 
and one active (HBsAg positive) HBV infection. The three patients with HCV exposure were 
discovered in religious venues, including one active infection with seven HBV exposures, 
and one active HBV infection.  
 
Discussion  
The South-Asian migrant population in the U.K. represent a higher-risk group that are often 
unaware of their CVH risk. We found it feasible to reach the target audience and recruit 
individuals from South-Asian groups to view a short educational film on CVH in community 
venues, with subsequent uptake of CVH testing and treatment if required. This study satisfied 
the major pre-defined criteria for success; 84% versus 40% of participants watching the film 
being tested.  Whilst there did not appear to be any relationship between film venue, gender, 
country of origin or level of education and decision-to-test, age appeared linked. Our cohort 
was skewed towards relatively older participants and while testing uptake appeared lower in 
younger people (57% [95% CI 18-90%] for 18-24 year olds), the small numbers viewing the 
film in this age range (n=8) precludes robust statistical inference. A particular success of our 
work was in the recruiting of  (i) the older age group and (ii) females (53%) to film screening,  
as well as testing for CVH as females are often underrepresented in prior studies [15], and 
likely due to holding events in culturally sensitive settings. We did find recruitment of 
females was more effective in community groups rather than religious settings. It may be that 
these pre-existing community groups gathered at a time during the day when children were at 




school and so there was more time to discuss this work. We found during our attendance at 
religious venues women were time pressured in their role as carer to children and other 
family members.  
 
Additionally, the study targeted inner city areas that were relatively deprived as well as more 
affluent areas of South-East England and we did not find any difference in ability to recruit to 
view the film nor testing for CVH. Notably, a number of participants (n=45) requested testing 
for CVH without having seen the intervention. This may suggest other factors including 
community endorsement may be relevant in testing. Anecdotally, these participants had an 
understanding of the risk factors for CVH and had knowledge of the wider work we had been 
undertaking in the community, suggesting that other forms of public interest messages have 
been successful e.g. providing test facilities at the same time increases uptake is impactful 
and achieves the objective of the educational program. Whilst possible the offer to test was 
taken up independently of the film, our experience suggests that word-of-mouth spread of 
information in this community appears critical.  
 
We identified finger-prick DBS testing as appropriate for the study, considering the 
community setting. However, results of these tests were not available immediately and 
required further contact with the participants to inform them of the results. A point-of-care 
test with immediate results could lessen the time and logistical burden of this type of outreach 
work, particularly given the nature of case-finding work in CVH requires mass testing. This 
may also allow a one-stop clinic where transient elastography, blood borne virus testing and 
onward treatment could be possible. However, careful consideration to maintaining 
confidentiality in the community setting would be essential.  
 




Considerations for a scale up and future RCT will be driven by those who will use this film 
locally and nationally. This will require engagement with key local and national Public 
Health agencies such as Public Health England, the National Screening Committee and 
Primary Care organizations as well as the Hepatology community, faith leaders, community 
organizations and the third-sector to deliver this sustainably. The advantage of this work is 
that the film intervention is now made. Therefore, for a full RCT we would have costs 
relating to technology (use of a laptop, projector and speaker system) to demonstrate the film 
in the community. These items were purchased as part of this study. For a wider roll out we 
would anticipate a further two set ups available to allow sessions to run at different sites. The 
costs for our feasibility work were related primarily to Staff costs which included a research 
assistant with knowledge of the community and languages. We propose to use a community 
based knowledge champion e.g. local councilor or faith group leader e.g. imam or 
alternatively knowledge advocate e.g. community pharmacist who will require initial training 
and ongoing salary costs but would aim to develop this role within existing operational 
delivery networks for Hepatitis C. The educational campaign would have to be modified to 
provide details on the number of people exposed and so exact costings are currently being 
determined. 
 
Whilst recognizing the feasibility nature of this study, we note limitations which are 
important to consider for a future RCT to test the efficacy of the intervention (see Table 2). 
Firstly, primary care recruitment was predictably poor which underlines the need for 
community setting  and less medical environment, identification of reasons for this would 
improve this dataset further, particularly in light of other studies recent success in this area 
[16]. A possible factor was that patients were informed of the educational event when 
attending an appointment with their healthcare provider and so may have had other health 




concerns at the time. A systematic method of identifying our target population such as health 
records search would allow us to reach more participants. Secondly, many of our participants 
were from older age groups (aged 61+) reflecting recruitment from community centers 
usually frequented by retired people. Film screenings were also held in the evenings and at 
weekends to try to balance this effect, and whilst we did recruit smaller numbers across other 
age ranges, our population remains skewed towards older participants and so our results may 
not be as applicable across other age groups. It is conceivable that younger migrants may be 
less likely to visit religious venues [17]. Thirdly, we were unable to establish a denominator 
for recruitment to assess how many participants opted to attend the film screening upon 
exposure to the advertising campaign. The nature of this study was to advertise to existing 
groups of people utilizing the recruitment venues, thus it was not possible to specifically 
assess those individuals who may have heard of this work but decided not to attend the event. 
In part, we believe this was related to the feasibility nature of this work and we have plans to 
address this in scale-up to an RCT. Completion of the pre and post-film questionnaires was 
inconsistent and did not meet the threshold we had set for success for this study. Future 
studies could be streamlined through registration (pre or on site) – access to records 
minimizes the time spent and help information back to primary care in real time.  
 
Despite limitations, this study has significant findings that warrant further assessment in a 
scaled up randomized trial. Whilst there is some data on case-finding in higher-risk minority 
groups these have mainly focused on offering a single opportunistic testing of those already 
engaged with healthcare services [18]. The UK hospitals working within the context of  
operational delivery networks (ODN)  have been tasked from moving from a traditional 
treatment role in HCV management only to also a case finding role which has traditionally 
fallen to public health. The importance of community based approach must not be 




underestimated and a need to validated tools to support hospitals to deliver this function and 
meet operational targets around treatment of cases.  
 
This study utilized the community itself to develop an educational intervention that provides 
information to the community on risk factors for CVH acquisition as well as offering advice 
on obtaining testing. This will help address reinfection and onwards transmission of CVH. As 
vertical infection is important in CVH acquisition our success in recruiting females was 
particularly important. Given the intervention we designed is culturally and linguistically 
tailored to the South-Asian community we hope this film could ultimately be widely 
available e.g. antenatal clinics in areas of high South-Asian populations, if proven effective in 
a randomized trial to raise awareness of CVH and its transmission. To the best of our 
knowledge there are no other studies examining the use of a film to provide education as well 
as offering testing. This method, once fully evaluated in an RCT, should be particularly 
useful in the real-world with the ready availability of technology such as social media and file 
sharing sites.  
 
Our study successfully addressed NICE and NHS England aims of offering testing, and 
indeed treatment, in areas familiar to the migrant community and we hope this model of 
healthcare engagement could help to address some of the barriers to healthcare more 
generally migrant communities face. 
 
 We tested higher-risk first generation migrants (South-Asian) groups for CVH, detected 
positive cases and subsequently linking patients successfully to care. This linkage to care is a 
fundamental factor in any intervention to improve testing rates for CVH and we recommend 
robust plans are made for this in the design of any study of this type. Equally, we believe it is 




important to test comprehensively for viral hepatitis including previous HBV exposure, 
particularly as modern healthcare is increasingly utilizing therapeutic agents that carry a risk 
of HBV reactivation and we counselled our patients on this risk and informed their primary 
care physician. 
 
The mode of transmission of infection of HBV and HCV  associated with CVH is similar but 
approaches to their prevention and treatment is different.  With respect to HBV the 
availability of an effective vaccine and access to antiviral therapy offer a realistic chance to 
treat and prevent CVH and liver cancer. In contrast, there is no specific vaccine to HCV but 
availability of effective antiviral agents and recent advances in therapies  are a welcome 
opportunity to control this infection and prevent chronic infection and liver cancer. Among 
other benefits, this study confirms the feasibility of adopting a strategy to ‘find, prevent and 
treat’ CVH and reduce the global burden of liver cancer.  Furthermore, this study has shown 
that it is feasible to apply this approach may be extended to undertake opportunistic screening 
or testing for other infections to address specific health inequalities, as appropriate. 
We believe that the benefits of this study are three-fold. Firstly, offering CVH testing and 
thus potential diagnosis and treatment to a higher-risk group; secondly, providing education 
to be shared more widely within the community and finally engagement of a higher-risk 
group with community based healthcare. Overall, we found a higher than anticipated uptake 
of testing for CVH after viewing the educational film, however, the feasibility nature of this 
study limits its ability to prove causation between the intervention and subsequent testing. 
The effectiveness of this study in promoting CVH testing has led to plans for an RCT to 
further evaluate this intervention. If successful, this could be the basis of a model to be 
utilized nationally and internationally in keeping with the emphasis on targeted case-finding, 
in line with the WHO plan for global CVH elimination. Whilst the study focused on CVH, it 




provides a model for general health education and screening for a wider range of conditions, 
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Figure 3: Characteristics of those testing for CVH after viewing the film, including 
percentage tested by gender, age, country of origin and educational attainment.  95% 2 sided 
confidence intervals are shown 
 
Figure 4: Testing for CVH by site, including 2 sided 95% confidence interval *97.5% one-







































Testing for CVH by venue type (%)




Figure 5: Number of participants testing by venue type including those testing through word 
of mouth  
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Males 23 74 5 102 47% 
Females 75 38 4 117 53% 
 Age 
18-24 - 7 - 8 4% 
25-40 1 24 4 29 13% 
41-50 1 16 1 18 8% 
51-60 8 17 2 27 12% 
61+ 87 45 2 133 61% 
unknown^ 1 3 - 4 2% 
 Country of Origin 
India 84 17 1 102 47% 
Pakistan 3 74 8 85 39% 
Bangladesh 6 19 - 25 11% 
Other South 
Asian 
5 2 - 7 3% 
 Highest Educational Attainment 
School 34 29 - 63 29% 
College 20 38 2 60 27% 
University 10 16 4 30 14% 
Professional 11 6 3 20 9% 
Unknown 23 23 - 46 21% 
Table 1b: Demographic details of those recruited for testing alone through word of mouth in 
the community 
 
DEMOGRAPHIC TESTED (N=) DEMOGRAPHIC TESTED (N=) 
Religious  Community 
Whole Cohort 14 Whole Cohort 31 
                                                       Gender 
males 12 males 17 
females 2 females 14 
Age 
18-24 2 18-24 0 
25-40 1 25-40 0 
41-50 2 41-50 3 
51-60 3 51-60 1 
61+ 6 61+ 27 




Table 2: Specific areas of concern and proposed details for future proposed scale up of RCT 
 
Trial activity Specific area of concern highlighted in 
feasibility study 
Proposed solution for scale 
up to trial 
Recruitment Low primary care recruitment number Targeted recruitment through: 
 (i) use of electronic health 
records data 
(ii) media including 
national/global key opinion 
leaders promoting testing e.g. 
Bollywood personality 
(iii) pathway finder to 
facilitating link between 
recruitment and primary care 
Participants mainly recruited from older 
age groups 
(i) explore delivery in new 
venues e.g. youth clubs, 
community groups, antenatal 
clinics in high south Asian 
populations as a venue to 
improve engagement with 
women  
(ii) peer lead recruitment  
(iii) promote social networks  
(iv) media including 
national/global key opinion 
leaders promoting testing e.g. 
Bollywood personality 
Results Hard to follow up with participants after 
point of care testing 
Undertake PPI to explore ways 
to simplify follow up:            
(i) via text messaging  
(ii) coordination via key link 
personnel through e.g. pathway 
finders supported by clinical 
commissioning groups. 
(iv) point of care testing results 
for hepatitis c RNA 
(v) one stop shop fibroscan –
hepatic elastography 
Low rates of questionnaire completion (i) simplify questionnaire 
(ii) real time onsite completion 
using tablet key pads 
 
 
